298 related articles for article (PubMed ID: 10706098)
21. Homophilic complex formation of MT1-MMP facilitates proMMP-2 activation on the cell surface and promotes tumor cell invasion.
Itoh Y; Takamura A; Ito N; Maru Y; Sato H; Suenaga N; Aoki T; Seiki M
EMBO J; 2001 Sep; 20(17):4782-93. PubMed ID: 11532942
[TBL] [Abstract][Full Text] [Related]
22. Plasmin activates pro-matrix metalloproteinase-2 with a membrane-type 1 matrix metalloproteinase-dependent mechanism.
Monea S; Lehti K; Keski-Oja J; Mignatti P
J Cell Physiol; 2002 Aug; 192(2):160-70. PubMed ID: 12115722
[TBL] [Abstract][Full Text] [Related]
23. Heat shock suppresses membrane type 1-matrix metalloproteinase production and progelatinase A activation in human fibrosarcoma HT-1080 cells and thereby inhibits cellular invasion.
Sato T; Sawaji Y; Matsui N; Sato H; Seiki M; Mori Y; Ito A
Biochem Biophys Res Commun; 1999 Nov; 265(1):189-93. PubMed ID: 10548512
[TBL] [Abstract][Full Text] [Related]
24. Biochemical characterization of the catalytic domain of membrane-type 4 matrix metalloproteinase.
Kolkenbrock H; Essers L; Ulbrich N; Will H
Biol Chem; 1999 Sep; 380(9):1103-8. PubMed ID: 10543448
[TBL] [Abstract][Full Text] [Related]
25. Activation of pro-MMP-2 mediated by MT1-MMP in human salivary gland carcinomas: possible regulation of pro-MMP-2 activation by TIMP-2.
Kayano K; Shimada T; Shinomiya T; Nakai S; Hisa Y; Aoki T; Seiki M; Okada Y
J Pathol; 2004 Apr; 202(4):403-11. PubMed ID: 15095267
[TBL] [Abstract][Full Text] [Related]
26. Expression and activation of matrix metalloproteinase-2 (MMP-2) and its co-localization with membrane-type 1 matrix metalloproteinase (MT1-MMP) correlate with melanoma progression.
Hofmann UB; Westphal JR; Zendman AJ; Becker JC; Ruiter DJ; van Muijen GN
J Pathol; 2000 Jul; 191(3):245-56. PubMed ID: 10878545
[TBL] [Abstract][Full Text] [Related]
27. Testican 2 abrogates inhibition of membrane-type matrix metalloproteinases by other testican family proteins.
Nakada M; Miyamori H; Yamashita J; Sato H
Cancer Res; 2003 Jun; 63(12):3364-9. PubMed ID: 12810672
[TBL] [Abstract][Full Text] [Related]
28. Identification and characterization of the fifth membrane-type matrix metalloproteinase MT5-MMP.
Pei D
J Biol Chem; 1999 Mar; 274(13):8925-32. PubMed ID: 10085137
[TBL] [Abstract][Full Text] [Related]
29. Activation of membrane-type matrix metalloproteinase 3 zymogen by the proprotein convertase furin in the trans-Golgi network.
Kang T; Nagase H; Pei D
Cancer Res; 2002 Feb; 62(3):675-81. PubMed ID: 11830519
[TBL] [Abstract][Full Text] [Related]
30. Identification and characterization of a novel human matrix metalloproteinase with unique structural characteristics, chromosomal location, and tissue distribution.
Pendás AM; Knäuper V; Puente XS; Llano E; Mattei MG; Apte S; Murphy G; López-Otín C
J Biol Chem; 1997 Feb; 272(7):4281-6. PubMed ID: 9020145
[TBL] [Abstract][Full Text] [Related]
31. Complex regulation of membrane-type matrix metalloproteinase expression and matrix metalloproteinase-2 activation by concanavalin A in MDA-MB-231 human breast cancer cells.
Yu M; Sato H; Seiki M; Thompson EW
Cancer Res; 1995 Aug; 55(15):3272-7. PubMed ID: 7614461
[TBL] [Abstract][Full Text] [Related]
32. Serum and plasma M(r) 92,000 progelatinase levels correlate with spontaneous metastasis of rat 13762NF mammary adenocarcinoma.
Nakajima M; Welch DR; Wynn DM; Tsuruo T; Nicolson GL
Cancer Res; 1993 Dec; 53(23):5802-7. PubMed ID: 8242639
[TBL] [Abstract][Full Text] [Related]
33. Membrane-type 1 matrix metalloproteinase-mediated progelatinase A activation in non-tumorigenic and tumorigenic human keratinocytes.
Baumann P; Zigrino P; Mauch C; Breitkreutz D; Nischt R
Br J Cancer; 2000 Nov; 83(10):1387-93. PubMed ID: 11044366
[TBL] [Abstract][Full Text] [Related]
34. Membrane type I-matrix metalloproteinase-mediated degradation of type I collagen by oral squamous cell carcinoma cells.
Aznavoorian S; Moore BA; Alexander-Lister LD; Hallit SL; Windsor LJ; Engler JA
Cancer Res; 2001 Aug; 61(16):6264-75. PubMed ID: 11507081
[TBL] [Abstract][Full Text] [Related]
35. Cell surface activation of progelatinase A (proMMP-2) and cell migration.
Nagase H
Cell Res; 1998 Sep; 8(3):179-86. PubMed ID: 9791731
[TBL] [Abstract][Full Text] [Related]
36. [Expression of membrane-type matrix metalloproteinase (MT-MMP) and activation of MMP-2 in lung cancer].
Tokuraku M; Sato H; Watanabe Y; Seiki M
Nihon Rinsho; 1995 Jul; 53(7):1822-6. PubMed ID: 7630026
[TBL] [Abstract][Full Text] [Related]
37. Catalytic activities and substrate specificity of the human membrane type 4 matrix metalloproteinase catalytic domain.
Wang Y; Johnson AR; Ye QZ; Dyer RD
J Biol Chem; 1999 Nov; 274(46):33043-9. PubMed ID: 10551873
[TBL] [Abstract][Full Text] [Related]
38. The soluble catalytic domain of membrane type 1 matrix metalloproteinase cleaves the propeptide of progelatinase A and initiates autoproteolytic activation. Regulation by TIMP-2 and TIMP-3.
Will H; Atkinson SJ; Butler GS; Smith B; Murphy G
J Biol Chem; 1996 Jul; 271(29):17119-23. PubMed ID: 8663332
[TBL] [Abstract][Full Text] [Related]
39. Expression of membrane-type matrix metalloproteinase in human gastric carcinomas.
Nomura H; Sato H; Seiki M; Mai M; Okada Y
Cancer Res; 1995 Aug; 55(15):3263-6. PubMed ID: 7614460
[TBL] [Abstract][Full Text] [Related]
40. A matrix metalloproteinase expressed on the surface of invasive tumour cells.
Sato H; Takino T; Okada Y; Cao J; Shinagawa A; Yamamoto E; Seiki M
Nature; 1994 Jul; 370(6484):61-5. PubMed ID: 8015608
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
